Vertex Pharmaceuticals, Inc. (VRTX)

441.36 +2.44 (+0.56%) USD  |  NASDAQ  |  Jan 16, 16:00
440.02 -1.34 (-0.30%) After-Hours: 20:00
More

Vertex Pharmaceuticals Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade